Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 2
2015 3
2016 3
2017 2
2018 7
2019 2
2020 2
2021 4
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Drug resistance and new therapies in colorectal cancer.
Van der Jeught K, Xu HC, Li YJ, Lu XB, Ji G. Van der Jeught K, et al. World J Gastroenterol. 2018 Sep 14;24(34):3834-3848. doi: 10.3748/wjg.v24.i34.3834. World J Gastroenterol. 2018. PMID: 30228778 Free PMC article. Review.
An organoid-based screen for epigenetic inhibitors that stimulate antigen presentation and potentiate T-cell-mediated cytotoxicity.
Zhou Z, Van der Jeught K, Fang Y, Yu T, Li Y, Ao Z, Liu S, Zhang L, Yang Y, Eyvani H, Cox ML, Wang X, He X, Ji G, Schneider BP, Guo F, Wan J, Zhang X, Lu X. Zhou Z, et al. Among authors: van der jeught k. Nat Biomed Eng. 2021 Nov;5(11):1320-1335. doi: 10.1038/s41551-021-00805-x. Epub 2021 Nov 1. Nat Biomed Eng. 2021. PMID: 34725507 Free PMC article.
Atractylenolide I enhances responsiveness to immune checkpoint blockade therapy by activating tumor antigen presentation.
Xu H, Van der Jeught K, Zhou Z, Zhang L, Yu T, Sun Y, Li Y, Wan C, So KM, Liu D, Frieden M, Fang Y, Mosley AL, He X, Zhang X, Sandusky GE, Liu Y, Meroueh SO, Zhang C, Wijeratne AB, Huang C, Ji G, Lu X. Xu H, et al. Among authors: van der jeught k. J Clin Invest. 2021 May 17;131(10):e146832. doi: 10.1172/JCI146832. J Clin Invest. 2021. PMID: 33830945 Free PMC article.
MAL2 drives immune evasion in breast cancer by suppressing tumor antigen presentation.
Fang Y, Wang L, Wan C, Sun Y, Van der Jeught K, Zhou Z, Dong T, So KM, Yu T, Li Y, Eyvani H, Colter AB, Dong E, Cao S, Wang J, Schneider BP, Sandusky GE, Liu Y, Zhang C, Lu X, Zhang X. Fang Y, et al. Among authors: van der jeught k. J Clin Invest. 2021 Jan 4;131(1):e140837. doi: 10.1172/JCI140837. J Clin Invest. 2021. PMID: 32990678 Free PMC article.
A T Cell-Engaging Tumor Organoid Platform for Pancreatic Cancer Immunotherapy.
Zhou Z, Van der Jeught K, Li Y, Sharma S, Yu T, Moulana I, Liu S, Wan J, Territo PR, Opyrchal M, Zhang X, Wan G, Lu X. Zhou Z, et al. Among authors: van der jeught k. Adv Sci (Weinh). 2023 Aug;10(23):e2300548. doi: 10.1002/advs.202300548. Epub 2023 Jun 4. Adv Sci (Weinh). 2023. PMID: 37271874 Free PMC article.
Adjuvant-Enhanced mRNA Vaccines.
Bialkowski L, Van der Jeught K, Renmans D, van Weijnen A, Heirman C, Keyaerts M, Breckpot K, Thielemans K. Bialkowski L, et al. Among authors: van der jeught k. Methods Mol Biol. 2017;1499:179-191. doi: 10.1007/978-1-4939-6481-9_11. Methods Mol Biol. 2017. PMID: 27987150
Editorial: Rising stars in cancer immunity and immunotherapy 2022.
Goyvaerts C, Engeland CE, Van der Jeught K. Goyvaerts C, et al. Among authors: van der jeught k. Front Immunol. 2023 Nov 7;14:1326374. doi: 10.3389/fimmu.2023.1326374. eCollection 2023. Front Immunol. 2023. PMID: 38022618 Free PMC article. No abstract available.
Author Correction: An organoid-based screen for epigenetic inhibitors that stimulate antigen presentation and potentiate T-cell-mediated cytotoxicity.
Zhou Z, Van der Jeught K, Fang Y, Yu T, Li Y, Ao Z, Liu S, Zhang L, Yang Y, Eyvani H, Cox ML, Wang X, He X, Ji G, Schneider BP, Guo F, Wan J, Zhang X, Lu X. Zhou Z, et al. Among authors: van der jeught k. Nat Biomed Eng. 2023 Aug 30. doi: 10.1038/s41551-023-01096-0. Online ahead of print. Nat Biomed Eng. 2023. PMID: 37648780 No abstract available.
Targeting the tumor microenvironment to enhance antitumor immune responses.
Van der Jeught K, Bialkowski L, Daszkiewicz L, Broos K, Goyvaerts C, Renmans D, Van Lint S, Heirman C, Thielemans K, Breckpot K. Van der Jeught K, et al. Oncotarget. 2015 Jan 30;6(3):1359-81. doi: 10.18632/oncotarget.3204. Oncotarget. 2015. PMID: 25682197 Free PMC article. Review.
ST2 as checkpoint target for colorectal cancer immunotherapy.
Van der Jeught K, Sun Y, Fang Y, Zhou Z, Jiang H, Yu T, Yang J, Kamocka MM, So KM, Li Y, Eyvani H, Sandusky GE, Frieden M, Braun H, Beyaert R, He X, Zhang X, Zhang C, Paczesny S, Lu X. Van der Jeught K, et al. JCI Insight. 2020 May 7;5(9):e136073. doi: 10.1172/jci.insight.136073. JCI Insight. 2020. PMID: 32376804 Free PMC article.
29 results